TDP-43 (human specific) Monoclonal antibody 60019-2-Ig proteintech

$149.00
In stock
SKU
60019-2-Ig
Catalog No.SizePrice (USD)
60019-2-IG-20UL20 μL$149.00
60019-2-IG-150UL150 μL$449.00
60019-2-IG-10X150UL1.5 mL (10 x 150 μL vials)$3,592.00
Catalog Number60019-2-Ig
SynonymsTARDBP, TDP 43, TDP43, TDP-43, 6H6E12
HostMouse
Reactivityhuman and More (1)
Reactivityhuman, yeast
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IHC, IP, CoIP, RIP, ELISA
ApplicationsWB, IHC, IP, ELISA
Host / IsotypeMouse / IgG1
Tested Applications — Positive WB detected inLNCaP cells, HeLa cells, HEK-293 cells, HepG2 cells, Jurkat cells, K-562 cells
Tested Applications — Positive IP detected inK-562 cells
Tested Applications — Positive IHC detected inhuman gliomas tissue, human brain(FTLD-U) tissue, human pancreas cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Recommended Dilutions — Western Blot (WB)WB : 1:5000-1:50000
Recommended Dilutions — Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Recommended Dilutions — Immunohistochemistry (IHC)IHC : 1:5000-1:20000
Positive WB detected inLNCaP cells, HeLa cells, HEK-293 cells, HepG2 cells, Jurkat cells, K-562 cells
Positive IP detected inK-562 cells
Positive IHC detected inhuman gliomas tissue, human brain(FTLD-U) tissue, human pancreas cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Western Blot (WB)WB : 1:5000-1:50000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:5000-1:20000
Tested Reactivityhuman
Cited Reactivityhuman, yeast
ClassMonoclonal
TypeAntibody
ImmunogenRecombinant protein Predict reactive species
Full NameTAR DNA binding protein
Calculated Molecular Weight43 kDa
Observed Molecular Weight43 kDa
GenBank Accession NumberBC001487
Gene SymbolTDP-43
Gene ID (NCBI)23435
RRIDAB_2200520
ConjugateUnconjugated
Purification MethodProtein G purification
UNIPROT IDQ13148
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
IHC protocol for TDP-43 (human specific) antibody 60019-2-IgDownload protocol
IP protocol for TDP-43 (human specific) antibody 60019-2-IgDownload protocol
WB protocol for TDP-43 (human specific) antibody 60019-2-IgDownload protocol
humanIHC Nat Neurosci TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTD Authors - Brian J Joseph View Article
Lidiya (Verified Customer) (05-26-2022)The antibody works great! Antibody was used for WB in Neuroblastoma cell lines (SK-N-BE(2)C and IMR32) with HRP-conjugated secondary. Antibody was also used for a Proximity Ligation Assay to assess interaction with another protein in SK-N-BE(2)C cells. 1:50 of antibody was used for this assay. Applications: Western Blot, Other Primary Antibody Dilution: 1:2000 (WB) Cell Tissue Type: Neuroblastoma Cell Lines TDP-43 (human specific) Antibody Western Blot,Other validation (1:2000 (WB) dilution) in Neuroblastoma Cell Lines (Cat no:60019-2-Ig)
David (Verified Customer) (01-13-2020)Great antibody for several applications. Works nicely for immunoblot and immunofluourescence. Can also be used for RNA immunoprecipitation. Applications: Western Blot, Immunofluorescence, Immunoprecipitation, Primary Antibody Dilution: 1:500 (IF); 1:1000 (WB); 30µg (RIP) Cell Tissue Type: SH-SY5Y
Citations132
DilutionsWB : 1:5000-1:50000 IP : 0.5-4.0 ug for IP and 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate for WB IHC : 1:5000-1:20000
IsotypeIgG1
ClonalityMonoclonal
Clone Number6H6E12
ConjugationUnconjugated

Transactivation response (TAR) DNA-binding protein of 43 kDa (also known as TARDBP or TDP-43) was first isolated as a transcriptional inactivator binding to the TAR DNA element of the HIV-1 virus. Neumann et al. (2006) found that a hyperphosphorylated, ubiquitinated, and cleaved form of TARDBP, known as pathologic TDP-43, is the major component of the tau-negative and ubiquitin-positive inclusions that characterize amyotrophic lateral sclerosis (ALS) and the most common pathological subtype of frontotemporal lobar degeneration (FTLD-U). Various forms of TDP-43 exist, including 18-35 kDa of cleaved C-terminal fragments, 45-50 kDa phospho-protein, 55 kDa glycosylated form, 75 kDa hyperphosphorylated form, and 90-300 kDa cross-linked form. (PMID: 17023659,19823856, 21666678, 22193176). 60019-2-Ig is a mouse monoclonal antibody recognizing the cleavage product of 20-30 kDa in addition to the native and phosphorylated forms of TDP-43. Immunohistochemical analyses of TDP-43 using this antibody detect both normal diffuse nuclear staining and insoluble inclusions in pathologic tissues. Notably this antibody only recognizes human TDP-43 but not reacts with mouse or rat TDP-43. Protocols Product Specific Protocols IHC protocol for TDP-43 (human specific) antibody 60019-2-Ig Download protocol IP protocol for TDP-43 (human specific) antibody 60019-2-Ig Download protocol WB protocol for TDP-43 (human specific) antibody 60019-2-Ig Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. A single-cell atlas of human and mouse white adipose tissue.
    Journal: Nature | Authors: Margo P Emont | Application: WB
  2. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia.
    Journal: Nature | Authors: Deng Han-Xiang HX | Species: human | Application: IHC
  3. Amyloid fibrils in disease FTLD-TDP are composed of TMEM106B not TDP-43.
    Journal: Nature | Authors: Yi Xiao Jiang | Species: human | Application: WB
  4. TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP
    Journal: Nature | Authors: Diana Arseni | Species: human | Application: WB,IHC
  5. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity.
    Journal: Nat Med | Authors: Wenzhang Wang | Species: human | Application: WB
  6. TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTD
    Journal: Nat Neurosci | Authors: Brian J Joseph | Species: human | Application: IHC
  7. TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTD
    Journal: Nat Neurosci | Authors: Brian J Joseph | Species: human | Application: IHC
  8. TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates.
    Journal: Nat Neurosci | Authors: Florent Laferrière
  9. Extracellular vesicles in TDP-43 proteinopathies: pathogenesis and biomarker potential
    Journal: Mol Neurodegener | Authors: Elizabeth R Dellar | Species: human | Application: WB
  10. Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice.
    Journal: Mol Neurodegener | Authors: Sarah Herdewyn | Species: human | Application: IHC
  11. In vivo diagnosis of TDP-43 proteinopathies: in search of biomarkers of clinical use
    Journal: Transl Neurodegener | Authors: Juan I López-Carbonero
  12. Endocytosis regulates TDP-43 toxicity and turnover.
    Journal: Nat Commun | Authors: Guangbo Liu | Species: human | Application: WB
  13. An acetylation switch controls TDP-43 function and aggregation propensity.
    Journal: Nat Commun | Authors: Todd J Cohen | Species: human | Application: WB,IP
  14. TDP-43 and PINK1 mediate CHCHD10S59L mutation-induced defects in Drosophila and in vitro.
    Journal: Nat Commun | Authors: Minwoo Baek | Species: human | Application: WB
  15. Endocytosis regulates TDP-43 toxicity and turnover.
    Journal: Nat Commun | Authors: Guangbo Liu | Species: human | Application: WB
  16. Inhibition of RNA splicing triggers CHMP7 nuclear entry, impacting TDP-43 function and leading to the onset of ALS cellular phenotypes
    Journal: Neuron | Authors: Norah Al-Azzam | Species: human
  17. Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia mice
    Journal: Neuron | Authors: Yazi D Ke | Species: human | Application: WB,IHC
  18. Targeting PGAM5-driven mitochondrial integrated stress response slows ALS progression across subtypes.
    Journal: Neuron | Authors: Zhilong Zheng | Species: human | Application: WB,IP,IHC
  19. Increased cytoplasmic TARDBP mRNA in affected spinal motor neurons in ALS caused by abnormal autoregulation of TDP-43.
    Journal: Nucleic Acids Res | Authors: Akihide Koyama
  20. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice.
    Journal: J Clin Invest | Authors: Igaz Lionel M LM | Species: human | Application: WB,IHC
  21. TDP-43/ALKBH5-mediated m6A modification of CDC25A mRNA promotes glioblastoma growth by facilitating G1/S cell cycle transition
    Journal: MedComm (2020) | Authors: Yunxiao Zhang | Species: human
  22. Quantitative Profiling of Nanoscopic Protein Aggregates Reveals Specific Fingerprint of TDP-43-Positive Assemblies in Motor Neuron Disease.
    Journal: Adv Sci (Weinh) | Authors: Dezerae Cox | Species: human | Application: IP
  23. A quantitative biology approach correlates neuronal toxicity with the largest inclusions of TDP-43
    Journal: Sci Adv | Authors: Roberta Cascella
  24. Astrocytic TDP-43 dysregulation impairs memory by modulating antiviral pathways and interferon-inducible chemokines
    Journal: Sci Adv | Authors: Avital Licht-Murava | Species: human | Application: WB
  25. Molecular analysis and biochemical classification of TDP-43 proteinopathy.
    Journal: Brain | Authors: Tsuji Hiroshi H | Species: human | Application: WB
  26. Mislocated FUS is sufficient for gain-of-toxic-function amyotrophic lateral sclerosis phenotypes in mice.
    Journal: Brain | Authors: Gen Shiihashi | Application: WB
  27. Homozygous GRN mutations: new phenotypes and new insights into pathological and molecular mechanisms.
    Journal: Brain | Authors: Vincent Huin | Species: human | Application: IHC
  28. A human Staufen1 BAC transgenic mouse exhibits abnormal autophagy and neurodegeneration across the central nervous system.
    Journal: Cell Death Dis | Authors: Stefan M. Pulst | Species: human | Application: WB
  29. Distinctive chaperonopathy in skeletal muscle associated with the dominant variant in DNAJB4
    Journal: Acta Neuropathol | Authors: Michio Inoue | Species: human
  30. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS.
    Journal: Acta Neuropathol | Authors: Yazi D Ke | Application: WB,IHC
  31. Distinctive chaperonopathy in skeletal muscle associated with the dominant variant in DNAJB4
    Journal: Acta Neuropathol | Authors: Michio Inoue | Species: human
  32. TDP-43 immunoreactivity in anoxic, ischemic and neoplastic lesions of the central nervous system.
    Journal: Acta Neuropathol | Authors: Lee Edward B EB | Species: human | Application: WB
  33. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS.
    Journal: Acta Neuropathol | Authors: Yazi D Ke | Application: WB,IHC
  34. Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking.
    Journal: EMBO J | Authors: Cohen Todd J TJ | Species: human | Application: WB
  35. A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing.
    Journal: EMBO J | Authors: Ailin Wang | Application: IP
  36. Loss of TDP-43 oligomerization or RNA binding elicits distinct aggregation patterns
    Journal: EMBO J | Authors: Manuela Pérez-Berlanga | Species: human | Application: WB
  37. Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking.
    Journal: EMBO J | Authors: Cohen Todd J TJ | Species: human | Application: WB
  38. Nuclear Import Receptors Directly Bind to Arginine-Rich Dipeptide Repeat Proteins and Suppress Their Pathological Interactions.
    Journal: Cell Rep | Authors: Saskia Hutten
  39. Prion-like Properties of Pathological TDP-43 Aggregates from Diseased Brains.
    Journal: Cell Rep | Authors: Nonaka Takashi T | Species: human | Application: WB
  40. Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation.
    Journal: J Neurol Neurosurg Psychiatry | Authors: Suárez-Calvet Marc M
  41. Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.
    Journal: Ann Neurol | Authors: Larman H Benjamin HB | Species: human | Application: IHC
  42. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.
    Journal: Ann Neurol | Authors: Deng Han-Xiang HX | Species: human | Application: WB,IHC
  43. Increasing Brain Permeability of PHA-767491, a Cell Division Cycle 7 Kinase Inhibitor, with Biodegradable Polymeric Nanoparticles.
    Journal: Pharmaceutics | Authors: Elisa Rojas-Prats | Species: human
  44. Spreading of TDP-43 pathology via pyramidal tract induces ALS-like phenotypes in TDP-43 transgenic mice.
    Journal: Acta Neuropathol Commun | Authors: Xuebing Ding | Application: WB,IHC
  45. Enhanced secretion of the amyotrophic lateral sclerosis ALS-associated misfolded TDP-43 mediated by the ER-ubiquitin specific peptidase USP19
    Journal: Cell Mol Life Sci | Authors: Flavien Picard | Species: human
  46. Phosphorylated and aggregated TDP-43 with seeding properties are induced upon mutant Huntingtin (mHtt) polyglutamine expression in human cellular models.
    Journal: Cell Mol Life Sci | Authors: Laurent Coudert | Species: human | Application: WB
  47. Targeting the TDP-43 low complexity domain blocks spreading of pathology in a mouse model of ALS/FTD
    Journal: Acta Neuropathol Commun | Authors: Elodie Chevalier | Species: human | Application: WB
  48. Pathological changes induced by Alzheimer's brain inoculation in amyloid-beta plaque-bearing mice
    Journal: Acta Neuropathol Commun | Authors: Suzanne Lam | Species: human | Application: IHC
  49. Enhanced secretion of the amyotrophic lateral sclerosis ALS-associated misfolded TDP-43 mediated by the ER-ubiquitin specific peptidase USP19
    Journal: Cell Mol Life Sci | Authors: Flavien Picard | Species: human
  50. Pathological changes induced by Alzheimer's brain inoculation in amyloid-beta plaque-bearing mice
    Journal: Acta Neuropathol Commun | Authors: Suzanne Lam | Species: human | Application: IHC
  51. Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration
    Journal: Acta Neuropathol Commun | Authors: Beibei Zhao | Species: human | Application: WB
  52. RBM45 associates with nuclear stress bodies and forms nuclear inclusions during chronic cellular stress and in neurodegenerative diseases.
    Journal: Acta Neuropathol Commun | Authors: Mahlon Collins | Species: human
  53. Development of a Sensitive and Reliable Meso Scale Discovery-Based Electrochemiluminescence Immunoassay to Quantify TDP-43 in Human Biofluids
    Journal: Biosensors (Basel) | Authors: Jiyan An
  54. Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction.
    Journal: Neurobiol Dis | Authors: David Gordon | Species: human | Application: IHC
  55. HDAC6 and TDP-43 promote autophagy impairment in amyotrophic lateral sclerosis
    Journal: Neurobiol Dis | Authors: Matteo Bordoni | Species: human | Application: WB,RIP
  56. Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction.
    Journal: Neurobiol Dis | Authors: David Gordon | Species: human | Application: IHC
  57. In vitro prion-like behaviour of TDP-43 in ALS.
    Journal: Neurobiol Dis | Authors: Phillip Smethurst | Species: human | Application: WB
  58. miR-23a suppression accelerates functional decline in the rNLS8 mouse model of TDP-43 proteinopathy.
    Journal: Neurobiol Dis | Authors: Stavroula Tsitkanou | Application: WB
  59. Association of UBQLN1 mutation with Brown-Vialetto-Van Laere syndrome but not typical ALS.
    Journal: Neurobiol Dis | Authors: González-Pérez Paloma P | Species: human
  60. Neuroimmune signaling mediates astrocytic nucleocytoplasmic disruptions and stress granule formation associated with TDP-43 pathology
    Journal: Neurobiol Dis | Authors: Constance Zhou
  61. Stress Granule Assembly Can Facilitate but Is Not Required for TDP-43 Cytoplasmic Aggregation.
    Journal: Biomolecules | Authors: Nikita Fernandes | Species: human
  62. Detection of Pathological Markers of Neurodegenerative Diseases following Microfluidic Direct Conversion of Patient Fibroblasts into Neurons.
    Journal: Int J Mol Sci | Authors: Cristiana Mollinari | Species: human
  63. Frontotemporal Lobar Degeneration Case with an N-Terminal TUBA4A Mutation Exhibits Reduced TUBA4A Levels in the Brain and TDP-43 Pathology.
    Journal: Biomolecules | Authors: Evelien Van Schoor | Species: human
  64. A Panel of miRNA Biomarkers Common to Serum and Brain-Derived Extracellular Vesicles Identified in Mouse Model of Amyotrophic Lateral Sclerosis
    Journal: Mol Neurobiol | Authors: Natasha Vassileff | Application: WB
  65. Estrogen Enhances Dendrite Spine Function and Recovers Deficits in Neuroplasticity in the prpTDP-43A315T Mouse Model of Amyotrophic Lateral Sclerosis.
    Journal: Mol Neurobiol | Authors: Emily E Handley | Application: WB
  66. Towards a TDP-43-Based Biomarker for ALS and FTLD.
    Journal: Mol Neurobiol | Authors: Emily Feneberg
  67. Early Cognitive/Social Deficits and Late Motor Phenotype in Conditional Wild-Type TDP-43 Transgenic Mice.
    Journal: Front Aging Neurosci | Authors: Julio A Alfieri | Species: human | Application: WB
  68. Perivascular phosphorylated TDP-43 inclusions are associated with Alzheimer's disease pathology and loss of CD146 and Aquaporin-4
    Journal: Brain Pathol | Authors: Jessica Santiago | Species: human | Application: IHC
  69. Atypical TDP-43 protein expression in an ALS pedigree carrying a p.Y374X truncation mutation in TARDBP.
    Journal: Brain Pathol | Authors: Thomas H Julian | Species: human | Application: WB
  70. Neurodegeneration and Motor Deficits in the Absence of Astrogliosis upon Transgenic Mutant TDP-43 Expression in Mature Mice.
    Journal: Am J Pathol | Authors: Gabriella Chan | Application: WB,IHC
  71. Split GFP technologies to structurally characterize and quantify functional biomolecular interactions of FTD-related proteins.
    Journal: Sci Rep | Authors: Chiara Foglieni | Species: human
  72. Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains.
    Journal: Sci Rep | Authors: Fuyuki Kametani | Species: human | Application: WB
  73. Dysfunction of the ubiquitin-proteasome system in the cerebellum of aging Ts65Dn mice.
    Journal: Exp Neurol | Authors: Necchi Daniela D | Application: IHC
  74. CdSe Quantum Dots in Human Models Derived from ALS Patients: Characterization, Nuclear Penetration Studies and Multiplexing.
    Journal: Nanomaterials (Basel) | Authors: Carlota Tosat-Bitrián | Species: human
  75. ALS skin fibroblasts reveal oxidative stress and ERK1/2-mediated cytoplasmic localization of TDP-43.
    Journal: Cell Signal | Authors: Nicla Romano | Species: human | Application: WB
  76. Pathologically mislocalised TDP-43 in upper motor neurons causes a die-forward spread of ALS-like pathogenic changes throughout the mouse corticomotor system
    Journal: Prog Neurobiol | Authors: Laura A Reale | Application: WB
  77. Tandem detergent-extraction and immunoprecipitation of proteinopathy: Scalable enrichment of ALS-associated TDP-43 aggregates
    Journal: iScience | Authors: Baggio A Evangelista
  78. ALS-associated TDP-43 aggregates drive innate and adaptive immune cell activation
    Journal: iScience | Authors: Baggio A Evangelista | Species: human | Application: WB
  79. Generation and analysis of innovative genomically humanized knockin SOD1, TARDBP (TDP-43), and FUS mouse models.
    Journal: iScience | Authors: Anny Devoy | Application: WB
  80. Reversible Behavioral Phenotypes in a Conditional Mouse Model of TDP-43 Proteinopathies.
    Journal: J Neurosci | Authors: Julio A Alfieri | Species: human | Application: WB
  81. Hsp90 and its co-chaperone Sti1 control TDP-43 misfolding and toxicity.
    Journal: FASEB J | Authors: Lilian Tsai-Wei Lin | Species: yeast | Application: WB,CoIP
  82. Templated aggregation of TDP-43 by seeding with TDP-43 peptide fibrils.
    Journal: J Biol Chem | Authors: Shotaro Shimonaka | Species: human | Application: WB
  83. Dysregulation of the Progranulin-driven Autophagy-lysosomal Pathway Mediates Secretion of the Nuclear Protein TDP-43
    Journal: J Biol Chem | Authors: Yoshinori Tanaka | Species: human | Application: WB
  84. Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43.
    Journal: J Biol Chem | Authors: Nishimoto Yoshinori Y | Species: human
  85. Regulation of RNG105/caprin1 dynamics by pathogenic cytoplasmic FUS and TDP-43 in neuronal RNA granules modulates synaptic loss
    Journal: Heliyon | Authors: Tomoyo Horio
  86. Pathological Proteins Are Transported by Extracellular Vesicles of Sporadic Amyotrophic Lateral Sclerosis Patients.
    Journal: Front Neurosci | Authors: Daisy Sproviero | Species: human | Application: WB
  87. Leukocyte Derived Microvesicles as Disease Progression Biomarkers in Slow Progressing Amyotrophic Lateral Sclerosis Patients.
    Journal: Front Neurosci | Authors: Daisy Sproviero | Species: human | Application: WB
  88. Nuclear bodies reorganize during myogenesis in vitro and are differentially disrupted by expression of FSHD-associated DUX4.
    Journal: Skelet Muscle | Authors: Sachiko Homma | Species: human
  89. Expression of FSHD-related DUX4-FL alters proteostasis and induces TDP-43 aggregation.
    Journal: Ann Clin Transl Neurol | Authors: Sachiko Homma | Species: human | Application: WB
  90. A Slower-Progressing TDP-43 rNLS8 Mouse Model for ALS: Implications for Preclinical and Mechanistic Studies
    Journal: Neuromolecular Med | Authors: Cyril Jones Jagaraj
  91. A Slower-Progressing TDP-43 rNLS8 Mouse Model for ALS: Implications for Preclinical and Mechanistic Studies
    Journal: Neuromolecular Med | Authors: Cyril Jones Jagaraj
  92. Amyotrophic lateral sclerosis mutant TDP-43 may cause synaptic dysfunction through altered dendritic spine function.
    Journal: Dis Model Mech | Authors: Tongcui Jiang | Species: human | Application: WB
  93. A Site-Specific Self-Association of a Protein Hub Drives Its Phase Separation.
    Journal: ACS Chem Biol | Authors: Mohammad Ahmad | Species: human
  94. Inclusion body myositis coexisting with hypertrophic cardiomyopathy: an autopsy study.
    Journal: Neuromuscul Disord | Authors: Inamori Yukie Y | Species: human | Application: IHC
  95. Multiple System Atrophy With Predominant Striatonigral Degeneration and TAR DNA-Binding Protein of 43 kDa Pathology: An Unusual Variant of Multiple System Atrophy.
    Journal: Mov Disord Clin Pract | Authors: Lynda Nwabuobi | Species: human | Application: IHC
  96. Extremely Early-Onset Frontotemporal Dementia: A Case Report and Literature Review
    Journal: J Alzheimers Dis | Authors: Min Chu | Species: human | Application: IHC
  97. Cytoplasmic Human TDP-43 Mislocalization Induces Widespread Dendritic Spine Loss in Mouse Upper Motor Neurons.
    Journal: Brain Sci | Authors: Marcus S Dyer | Species: human | Application: IHC
  98. Transthyretin abnormalities in amyotrophic lateral sclerosis: High molecular weight species in cerebrospinal fluid and stromal deposits in choroid plexus
    Journal: J Neuropathol Exp Neurol | Authors: Mahlon Collins
  99. Identification of disease-associated molecular signatures in the Prp-TDP-43A315T mouse model of ALS: Toward preclinical biomarker development.
    Journal: J Neuropathol Exp Neurol | Authors: Yara Al Ojaimi | Application: WB
  100. A unique mouse model for investigating the properties of amyotrophic lateral sclerosis-associated protein TDP-43, by in utero electroporation.
    Journal: Neurosci Res | Authors: Akamatsu Megumi M | Species: human
  101. Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease.
    Journal: Brain Res | Authors: Troy T Rohn | Species: human | Application: WB,IHC
  102. Gain-of-function profilin 1 mutations linked to familial amyotrophic lateral sclerosis cause seed-dependent intracellular TDP-43 aggregation.
    Journal: Hum Mol Genet | Authors: Yoshinori Tanaka | Species: human | Application: WB
  103. Gain-of-function profilin 1 mutations linked to familial amyotrophic lateral sclerosis cause seed-dependent intracellular TDP-43 aggregation.
    Journal: Hum Mol Genet | Authors: Yoshinori Tanaka | Species: human | Application: WB
  104. Progranulin regulates lysosomal function and biogenesis through acidification of lysosomes.
    Journal: Hum Mol Genet | Authors: Yoshinori Tanaka | Species: human | Application: WB
  105. Aberrant NSUN1 activity connects m(5)C-RNA modification to TDP-43 neurotoxicity in ALS/FTD.
    Journal: Life Sci Alliance | Authors: Melissa Parra-Torres | Species: human | Application: WB,IP
  106. Evidence of a link between ubiquilin 2 and optineurin in amyotrophic lateral sclerosis.
    Journal: Hum Mol Genet | Authors: Mayuko Osaka
  107. Distinct pathways leading to TDP-43-induced cellular dysfunctions.
    Journal: Hum Mol Genet | Authors: Makiko Yamashita | Species: human | Application: WB
  108. The dual functions of the extreme N-terminus of TDP-43 in regulating its biological activity and inclusion formation.
    Journal: Hum Mol Genet | Authors: Zhang Yong-Jie YJ | Species: human | Application: WB
  109. Clinicopathological features of the first Asian family having vocal cord and pharyngeal weakness with distal myopathy due to a MATR3 mutation.
    Journal: Neuropathol Appl Neurobiol | Authors: Satoshi Yamashita | Species: human
  110. The role of lysosomes and autophagosomes in Frontotemporal Lobar Degeneration.
    Journal: Neuropathol Appl Neurobiol | Authors: Hamish Dc Bain | Species: human
  111. Synapse Dysfunction of Layer V Pyramidal Neurons Precedes Neurodegeneration in a Mouse Model of TDP-43 Proteinopathies.
    Journal: Cereb Cortex | Authors: Emily E Handley | Species: human
  112. TDP-43 pathology and functional deficits in wild-type and ALS/FTD mutant cyclin F mouse models
    Journal: Neuropathol Appl Neurobiol | Authors: Annika van Hummel | Application: WB
  113. Cdc48/VCP and Endocytosis Regulate TDP-43 and FUS Toxicity and Turnover.
    Journal: Mol Cell Biol | Authors: Guangbo Liu
  114. TDP-43, an ALS Linked Protein, Regulates Fat Deposition and Glucose Homeostasis.
    Journal: PLoS One | Authors: Stallings Nancy R NR | Species: human | Application: WB,IHC
  115. Cdc48/VCP and Endocytosis Regulate TDP-43 and FUS Toxicity and Turnover.
    Journal: Mol Cell Biol | Authors: Guangbo Liu
  116. Coaggregation of RNA-binding proteins in a model of TDP-43 proteinopathy with selective RGG motif methylation and a role for RRM1 ubiquitination.
    Journal: PLoS One | Authors: Dammer Eric B EB | Species: human
  117. RBM45 modulates the antioxidant response in ALS through interactions with KEAP1.
    Journal: Mol Cell Biol | Authors: Nadine Bakkar | Species: human | Application: WB
  118. Epitope mapping of antibodies against TDP-43 and detection of protease-resistant fragments of pathological TDP-43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Journal: Biochem Biophys Res Commun | Authors: Tsuji Hiroshi H | Species: human | Application: WB
  119. AMSH is required to degrade ubiquitinated proteins in the central nervous system.
    Journal: Biochem Biophys Res Commun | Authors: Suzuki Shunya S | Application: IHC
  120. Frontotemporal dementia with trans-activation response DNA-binding protein 43 presenting with catatonic syndrome.
    Journal: Neuropathology | Authors: Ryohei Watanabe | Species: human | Application: WB
  121. Frontotemporal dementia with trans-activation response DNA-binding protein 43 presenting with catatonic syndrome.
    Journal: Neuropathology | Authors: Ryohei Watanabe | Species: human | Application: WB
  122. Pathological Comparison of TDP-43 Between Motor Neurons and Interneurons Expressed by a Tetracycline Repressor System on the Mouse Artificial Chromosome
    Journal: Yonago Acta Med | Authors: Shota Togai | Application: WB
  123. TDP-43 pathology is linked to motor neuron loss but is independent of stress granules in vivo.
    Journal: bioRxiv | Authors: Alicia Dubinski | Species: human | Application: WB
  124. Non-canonical amino acid incorporation enables minimally disruptive labeling of stress granule and TDP-43 proteinopathy.
    Journal: Elife | Authors: Hao Chen
  125. Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism.
    Journal: Elife | Authors: Erin G Conlon | Species: human | Application: CoIP
  126. Noncanonical amino acid incorporation enables minimally disruptive labeling of stress granule and TDP-43 proteinopathy.
    Journal: bioRxiv | Authors: Hao Chen | Species: human
  127. Genetic suppression of myeloid receptor Clec7a attenuates microglia neuroinflammation and promotes microglial phagocytosis to delay disease progression in ALS models.
    Journal: bioRxiv | Authors: Xuan Chen
  128. Non-canonical amino acid incorporation enables minimally disruptive labeling of stress granule and TDP-43 proteinopathy.
    Journal: Elife | Authors: Hao Chen
  129. Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism.
    Journal: Elife | Authors: Erin G Conlon | Species: human | Application: CoIP
  130. TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Journal: Arch Neurol | Authors: Steinacker Petra P | Species: human | Application: WB
  131. Context-dependent Interactors Regulate TDP-43 Dysfunction in ALS/FTLD
    Journal: bioRxiv | Authors: Longxin Xie | Species: human | Application: WB
  132. Neuropathology of centenarians and supercentenarians: An autopsy study.
    Journal: Neurobiol Aging | Authors: Shino Magaki | Species: human | Application: IHC
  133. Neuropathology of centenarians and supercentenarians: An autopsy study.
    Journal: Neurobiol Aging | Authors: Shino Magaki | Species: human | Application: IHC

Reviews

Write Your Own Review
You're reviewing:TDP-43 (human specific) Monoclonal antibody 60019-2-Ig proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.